Professor Raj Chopra
Director, Cancer Research UK, Cancer Therapeutics Unit, Head, Division of Cancer Therapeutics
The Institute of Cancer Research
Professor Rajesh Chopra, FRCP, FRCPath, PhD
Director Cancer Research UK Cancer Therapeutics Unit, Head Division of Cancer Therapeutics, The Institute of Cancer Research, London
Professor Raj Chopra trained in Medicine at University College London. He then completed his training in general medicine at major teaching hospitals in London gaining Membership of the Royal College of Physicians. He undertook a PhD in cell signaling and growth receptors followed by a postdoctoral fellowship at the Waller Eliza Hall Institute in Melbourne, Australia. He is also an alumnus of the University of Virginia Darden Business School having completed the Executive Program in 2015. There he worked for Professor D Metcalf who was the first to culture human hematopoietic stem cells and discover both G and GM-CSF. Subsequently, he worked with Professor M Dexter (latterly Director of the Wellcome Trust) setting up his own research group in Stem Cell and Leukemia Biology at the Paterson Institute of Cancer Research. At the same time he was appointed Director of Hematological Oncology, leading one of the largest Bone Marrow Transplant and Leukemia Programs in Europe at the Christie Hospital in Manchester. From 2004 to 2009, he was part of the leadership team for the largest Oncology group in AstraZeneca and established Translational Medicine for AstraZeneca in Boston, MA.